MSFT   181.34 (-0.03%)
FB   224.30 (-0.52%)
AMZN   2,405.73 (+0.19%)
NVDA   342.43 (+0.87%)
CGC   17.51 (-19.38%)
BABA   197.63 (-0.93%)
GE   6.53 (-3.69%)
AMD   52.12 (+0.73%)
GILD   74.91 (-0.54%)
DIS   115.47 (-1.03%)
NFLX   415.00 (+0.38%)
BAC   24.54 (-1.21%)
BA   145.68 (-2.76%)
MSFT   181.34 (-0.03%)
FB   224.30 (-0.52%)
AMZN   2,405.73 (+0.19%)
NVDA   342.43 (+0.87%)
CGC   17.51 (-19.38%)
BABA   197.63 (-0.93%)
GE   6.53 (-3.69%)
AMD   52.12 (+0.73%)
GILD   74.91 (-0.54%)
DIS   115.47 (-1.03%)
NFLX   415.00 (+0.38%)
BAC   24.54 (-1.21%)
BA   145.68 (-2.76%)
MSFT   181.34 (-0.03%)
FB   224.30 (-0.52%)
AMZN   2,405.73 (+0.19%)
NVDA   342.43 (+0.87%)
CGC   17.51 (-19.38%)
BABA   197.63 (-0.93%)
GE   6.53 (-3.69%)
AMD   52.12 (+0.73%)
GILD   74.91 (-0.54%)
DIS   115.47 (-1.03%)
NFLX   415.00 (+0.38%)
BAC   24.54 (-1.21%)
BA   145.68 (-2.76%)
MSFT   181.34 (-0.03%)
FB   224.30 (-0.52%)
AMZN   2,405.73 (+0.19%)
NVDA   342.43 (+0.87%)
CGC   17.51 (-19.38%)
BABA   197.63 (-0.93%)
GE   6.53 (-3.69%)
AMD   52.12 (+0.73%)
GILD   74.91 (-0.54%)
DIS   115.47 (-1.03%)
NFLX   415.00 (+0.38%)
BAC   24.54 (-1.21%)
BA   145.68 (-2.76%)
Log in

NASDAQ:CRSPCrispr Therapeutics SEC Filings & 10K Form

$62.73
+0.42 (+0.67 %)
(As of 05/29/2020 10:49 AM ET)
Add
Compare
Today's Range
$62.18
Now: $62.73
$63.77
50-Day Range
$41.29
MA: $54.94
$69.94
52-Week Range
$32.30
Now: $62.73
$74.00
Volume5,027 shs
Average Volume1.02 million shs
Market Capitalization$3.83 billion
P/E Ratio83.64
Dividend YieldN/A
Beta2.26

SEC Filings

Crispr Therapeutics (NASDAQ:CRSP) SEC Filings

DateFilerForm TypeView
05/27/2020
3:34 PM
Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
3:32 PM
Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
3:37 PM
Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
3:35 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
8:11 AM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2020
3:38 PM
Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
8:12 AM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2020
3:50 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2020
10:01 AM
Crispr Therapeutics (Filer)
Form D/A
04/09/2020
3:42 PM
Crispr Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
03/12/2020
3:20 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
3:20 PM
Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
3:20 PM
Crispr Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2020
3:10 PM
Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
3:13 PM
Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
3:13 PM
Crispr Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2020
2:19 PM
Crispr Therapeutics (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G
02/12/2020
5:02 AM
Crispr Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G
01/29/2020
3:16 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2020
3:09 PM
Bayer Global Investments B.V. (Filed by)
Crispr Therapeutics (Subject)
Form SC 13D/A
01/10/2020
3:49 PM
Bayer Global Investments B.V. (Filed by)
Crispr Therapeutics (Subject)
Form SC 13D/A
12/27/2019
3:06 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
6:01 AM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2019
3:05 PM
Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
3:05 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
3:05 PM
Crispr Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
4:12 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
6:53 PM
Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
3:12 PM
Crispr Therapeutics (Filer)
Form 424B5
11/21/2019
3:09 PM
Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
3:07 PM
CAGNONI PABLO J (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
3:27 PM
Crispr Therapeutics (Filer)
Form 424B5
11/19/2019
7:21 AM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
3:30 PM
CAGNONI PABLO J (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2019
5:35 PM
CAGNONI PABLO J (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2019
5:34 PM
Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
7:01 AM
Crispr Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2019
6:05 AM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
3:33 PM
Crispr Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2019
3:32 PM
Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2019
3:23 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2019
3:10 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2019
3:08 PM
Crispr Therapeutics (Filer)
Form 424B5
08/05/2019
4:49 PM
Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
3:32 PM
Crispr Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/29/2019
3:20 PM
Crispr Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2019
3:05 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2019
3:13 PM
Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
3:10 PM
Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
1:28 PM
Crispr Therapeutics (Subject)
Versant Venture Capital IV, L.P. (Filed by)
Form SC 13D/A
06/26/2019
7:45 AM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
3:15 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
7:49 PM
Crispr Therapeutics (Issuer)
High Katherine A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
7:42 PM
Crispr Therapeutics (Issuer)
High Katherine A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/13/2019
4:07 PM
Behbahani Ali (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
4:05 PM
Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
4:05 PM
Crispr Therapeutics (Issuer)
Greene John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
4:04 PM
CAGNONI PABLO J (Reporting)
Crispr Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
4:04 PM
Crispr Therapeutics (Issuer)
George Simeon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:44 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2019
3:16 PM
Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:04 PM
Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
Form SC 13D/A
06/06/2019
4:20 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2019
3:25 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2019
3:07 PM
Crispr Therapeutics (Filer)
Form DEFA14A
04/29/2019
3:05 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
6:27 AM
Crispr Therapeutics (Filer)
Form PRER14A
04/23/2019
1:34 PM
Crispr Therapeutics (Filer)
Form PRER14A
04/09/2019
3:15 PM
Crispr Therapeutics (Filer)
Form PRE 14A
03/07/2019
3:17 PM
Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
3:14 PM
Crispr Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
3:14 PM
Crispr Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
3:12 PM
Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
3:11 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
3:10 PM
Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2019
4:32 PM
Crispr Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2019
7:16 AM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2019
7:15 AM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2019
9:21 AM
Crispr Therapeutics (Subject)
New Enterprise Associates 15, L.P. (Filed by)
Form SC 13G/A
01/18/2019
3:32 PM
Crispr Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4/A
01/10/2019
3:09 PM
Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
3:32 PM
Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2018
3:34 PM
Crispr Therapeutics (Issuer)
Vertex Pharmaceuticals Ltd (0001761216) (Reporting)
VERTEX PHARMACEUTICALS INC / MA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2018
3:30 PM
Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
Form SC 13D/A
12/26/2018
3:35 PM
Crispr Therapeutics (Issuer)
Vertex Pharmaceuticals Ltd (0001761216) (Reporting)
VERTEX PHARMACEUTICALS INC / MA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2018
3:33 PM
Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
Form SC 13D/A
12/21/2018
4:16 PM
Crispr Therapeutics (Issuer)
Vertex Pharmaceuticals Ltd (0001761216) (Reporting)
VERTEX PHARMACEUTICALS INC / MA (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/21/2018
4:14 PM
Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
Form SC 13D
12/19/2018
3:22 PM
Crispr Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
3:29 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2018
4:29 PM
Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
10:08 AM
Crispr Therapeutics (Filer)
Form CT ORDER
11/07/2018
4:22 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2018
4:25 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2018
7:23 PM
Crispr Therapeutics (Filer)
Form 424B5
09/24/2018
4:27 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2018
3:16 PM
Crispr Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2018
3:10 PM
Crispr Therapeutics (Filer)
Form 424B5
09/19/2018
3:21 PM
Crispr Therapeutics (Filer)
Form 424B5
09/19/2018
3:02 PM
Crispr Therapeutics (Filer)
Form S-3ASR
This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.